A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report

por Watanabe, Takeshi, Furuse, Junji, Okano, Naohiro, Suzuki, Yutaka, Kamma, Hiroshi, Sugiyama, Masanori
Publicado 2017

Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II Study

por Naruge, Daisuke, Nagashima, Fumio, Kawai, Kirio, Okano, Naohiro, Kobayashi, Takaaki, Furuse, Junji
Publicado 2020

An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors

por Furuse, Junji, Kurata, Takayasu, Okano, Naohiro, Fujisaka, Yasuhito, Naruge, Daisuke, Shimizu, Toshio, Kitamura, Hiroshi, Iwasa, Tsutomu, Nagashima, Fumio, Nakagawa, Kazuhiko
Publicado 2018

A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer

por Takahara, Naminatsu, Nakai, Yousuke, Isayama, Hiroyuki, Sasaki, Takashi, Morine, Yuji, Watanabe, Kazuo, Ueno, Makoto, Ioka, Tatsuya, Kanai, Masashi, Kondo, Shunsuke, Okano, Naohiro, Koike, Kazuhiko
Publicado 2022

Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression

por Matsuki, Ryota, Okano, Naohiro, Hasui, Nobuhiro, Kawaguchi, Shohei, Momose, Hirokazu, Kitahama, Keiichiro, Nagahama, Kiyotaka, Kogure, Masaharu, Suzuki, Yutaka, Nagashima, Fumio, Shibahara, Junji, Mori, Hideaki, Sakamoto, Yoshihiro
Publicado 2022

First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Yoh, Kiyotaka, Shitara, Kohei, Takahashi, Hideaki, Ueno, Makoto, Kobayashi, Satoshi, Morimoto, Manabu, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Okano, Naohiro, Nagashima, Fumio, Furuse, Junji
Publicado 2018

A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer

por Okano, Naohiro, Matsuki, Ryota, Toki, Masao, Gondo, Koichi, Ochiai, Kazushige, Watanabe, Shunsuke, Tateishi, Hidekatsu, Kogure, Masaharu, Suzuki, Yutaka, Sugiyama, Masanori, Nagashima, Fumio, Shibahara, Junji, Sakamoto, Yoshihiro, Furuse, Junji
Publicado 2022

Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX

por Shirasu, Hiromichi, Todaka, Akiko, Omae, Katsuhiro, Fujii, Hirofumi, Mizuno, Nobumasa, Ozaka, Masato, Ueno, Hideki, Kobayashi, Satoshi, Uesugi, Kazuhiro, Kobayashi, Noritoshi, Hayashi, Hideyuki, Sudo, Kentaro, Okano, Naohiro, Horita, Yosuke, Kamei, Keiko, Yukisawa, Seigo, Kobayashi, Marina, Fukutomi, Akira
Publicado 2018

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Rand...

por Morizane, Chigusa, Machida, Nozomu, Honma, Yoshitaka, Okusaka, Takuji, Boku, Narikazu, Kato, Ken, Nomura, Shogo, Hiraoka, Nobuyoshi, Sekine, Shigeki, Taniguchi, Hirokazu, Okano, Naohiro, Yamaguchi, Kensei, Sato, Takuji, Ikeda, Masafumi, Mizuno, Nobumasa, Ozaka, Masato, Kataoka, Tomoko, Ueno, Makoto, Kitagawa, Yuko, Terashima, Masanori, Furuse, Junji
Publicado 2022

Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment

por Imaoka, Hiroshi, Ikeda, Masafumi, Umemoto, Kumiko, Sunakawa, Yu, Ueno, Makoto, Ueno, Hideki, Ozaka, Masato, Kuwahara, Takamichi, Okano, Naohiro, Kanai, Masashi, Hisano, Terumasa, Suzuki, Yuko, Asagi, Akinori, Shioji, Kazuhiko, Todaka, Akiko, Tsuji, Kunihiro, Ikezawa, Kenji, Miki, Ikuya, Komatsu, Yoshito, Akutsu, Noriyuki, Yamashita, Tatsuya, Okuyama, Hiroyuki, Furuse, Junji, Nagano, Hiroaki
Publicado 2023

Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy

por Aoki, Yu, Nakamura, Yoshiaki, Denda, Tadamichi, Ohta, Takashi, Esaki, Taito, Shiozawa, Manabu, Yamaguchi, Kensei, Yamazaki, Kentaro, Sunakawa, Yu, Kato, Takeshi, Okano, Naohiro, Taniguchi, Hiroya, Sato, Taro, Oki, Eiji, Nishina, Tomohiro, Komatsu, Yoshito, Matsuhashi, Nobuhisa, Goto, Masahiro, Yasui, Hisateru, Ohtsubo, Koushiro, Moriwaki, Toshikazu, Takahashi, Naoki, Horita, Yosuke, Boku, Shogen, Wakabayashi, Masashi, Ikeno, Takashi, Mitani, Ryuta, Yuasa, Mihoko, Yoshino, Takayuki
Publicado 2023

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer

por Jogo, Tomoko, Nakamura, Yoshiaki, Shitara, Kohei, Bando, Hideaki, Yasui, Hisateru, Esaki, Taito, Terazawa, Tetsuji, Satoh, Taroh, Shinozaki, Eiji, Nishina, Tomohiro, Sunakawa, Yu, Komatsu, Yoshito, Hara, Hiroki, Oki, Eiji, Matsuhashi, Nobuhisa, Ohta, Takashi, Kato, Takeshi, Ohtsubo, Koushiro, Kawakami, Takeshi, Okano, Naohiro, Yamamoto, Yoshiyuki, Yamada, Takanobu, Tsuji, Akihito, Odegaard, Justin I., Taniguchi, Hiroya, Doi, Toshihiko, Fujii, Satoshi, Yoshino, Takayuki
Publicado 2021

Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

por Kawabata, Ryohei, Chin, Keisho, Takahari, Daisuke, Hosaka, Hisashi, Muto, Osamu, Shindo, Yoshiaki, Nagata, Naoki, Yabusaki, Hiroshi, Imamura, Hiroshi, Endo, Shunji, Kashiwada, Tomomi, Nakamura, Masato, Hihara, Jun, Kobayashi, Michiya, Sagawa, Tamotsu, Saito, Soh, Sato, Atsushi, Yamada, Takeshi, Okano, Naohiro, Shimada, Ken, Matsushima, Masashi, Kataoka, Masato, Matsumoto, Shigemi, Goto, Masahiro, Kotaka, Masahito, Shiraishi, Takeshi, Yamai, Hiromichi, Nagashima, Fumio, Ishizuka, Naoki, Yamaguchi, Kensei
Publicado 2023

The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113

por Yamada, Ikuhiro, Morizane, Chigusa, Okusaka, Takuji, Mizusawa, Junki, Kataoka, Tomoko, Ueno, Makoto, Ikeda, Masafumi, Okano, Naohiro, Todaka, Akiko, Shimizu, Satoshi, Mizuno, Nobumasa, Sekimoto, Mitsugu, Tobimatsu, Kazutoshi, Yamaguchi, Hironori, Nishina, Tomohiro, Shirakawa, Hirofumi, Kojima, Yasushi, Oono, Takamasa, Kawamoto, Yasuyuki, Furukawa, Masayuki, Iwai, Tomohisa, Sudo, Kentaro, Okamura, Keiya, Yamashita, Tatsuya, Kato, Naoya, Shioji, Kazuhiko, Shimizu, Kyouko, Nakagohri, Toshio, Kamata, Ken, Ishii, Hiroshi, Furuse, Junji
Publicado 2022

Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemi...

por Mizuno, Nobumasa, Ioka, Tatsuya, Ogawa, Gakuto, Nakamura, Satoaki, Hiraoka, Nobuyoshi, Ito, Yoshinori, Katayama, Hiroshi, Takada, Ryoji, Kobayashi, Satoshi, Ikeda, Masafumi, Miwa, Haruo, Okano, Naohiro, Kuramochi, Hidekazu, Sekimoto, Mitsugu, Okusaka, Takuji, Ozaka, Masato, Todaka, Akiko, Gotoh, Kunihito, Tobimatsu, Kazutoshi, Yamaguchi, Hironori, Nakagohri, Toshio, Kajiura, Shinya, Sudo, Kentaro, Okamura, Keiya, Shimizu, Satoshi, Shirakawa, Hirofumi, Kato, Naoya, Sano, Keiji, Iwai, Tomohisa, Fujimori, Nao, Ueno, Makoto, Ishii, Hiroshi, Furuse, Junji
Publicado 2023

Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer

por Kobayashi, Satoshi, Suzuki, Motoko, Ueno, Makoto, Maruki, Yuta, Okano, Naohiro, Todaka, Akiko, Ozaka, Masato, Tsuji, Kunihiro, Shioji, Kazuhiko, Doi, Keitaro, Kojima, Yasushi, Tsumura, Hidetaka, Tanaka, Kazunari, Higuchi, Hajime, Kawabe, Ken, Imaoka, Hiroshi, Yamashita, Tatsuya, Miwa, Haruo, Nagano, Hiroaki, Arima, Shiho, Hayashi, Hideyuki, Naganuma, Atsushi, Yamaguchi, Hironori, Hisano, Terumasa, Umemoto, Kumiko, Ishii, Shuji, Nakashima, Koji, Suzuki, Rei, Kitano, Yohei, Misumi, Toshihiro, Furuse, Junji, Ishii, Hiroshi
Publicado 2022

Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy

por Nakamura, Yoshiaki, Okamoto, Wataru, Denda, Tadamichi, Nishina, Tomohiro, Komatsu, Yoshito, Yuki, Satoshi, Yasui, Hisateru, Esaki, Taito, Sunakawa, Yu, Ueno, Makoto, Shinozaki, Eiji, Matsuhashi, Nobuhisa, Ohta, Takashi, Kato, Ken, Ohtsubo, Koushiro, Bando, Hideaki, Hara, Hiroki, Satoh, Taroh, Yamazaki, Kentaro, Yamamoto, Yoshiyuki, Okano, Naohiro, Terazawa, Tetsuji, Kato, Takeshi, Oki, Eiji, Tsuji, Akihito, Horita, Yosuke, Hamamoto, Yasuo, Kawazoe, Akihito, Nakajima, Hiromichi, Nomura, Shogo, Mitani, Ryuta, Yuasa, Mihoko, Akagi, Kiwamu, Yoshino, Takayuki
Publicado 2022

Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113

por Ueno, Makoto, Morizane, Chigusa, Okusaka, Takuji, Mizusawa, Junki, Kataoka, Tomoko, Ikeda, Masafumi, Ozaka, Masato, Okano, Naohiro, Sugimori, Kazuya, Todaka, Akiko, Shimizu, Satoshi, Mizuno, Nobumasa, Yamamoto, Tomohisa, Sano, Keiji, Tobimatsu, Kazutoshi, Katanuma, Akio, Miyamoto, Atsushi, Yamaguchi, Hironori, Nishina, Tomohiro, Shirakawa, Hirofumi, Kojima, Yasushi, Oono, Takamasa, Kawamoto, Yasuyuki, Furukawa, Masayuki, Iwai, Tomohisa, Sudo, Kentaro, Miyakawa, Hiroyuki, Yamashita, Tatsuya, Yasuda, Ichirou, Takahashi, Hidenori, Kato, Naoya, Shioji, Kazuhiko, Shimizu, Kyoko, Nakagohri, Toshio, Kamata, Ken, Ishii, Hiroshi, Furuse, Junji
Publicado 2021